Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
more »
- Charité Centrum für Therapieforschung, Charité—Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Inst. of Health, Berlin (Germany); Einstein Center Digital Future, Berlin (Germany); Monarch Initiative (monarchinitiative.org); DOE/OSTI
- Monarch Initiative (monarchinitiative.org); The Jackson Lab. for Genomic Medicine, Farmington, CT (United States)
- Monarch Initiative (monarchinitiative.org); Oregon Health & Science Univ., Portland, OR (United States)
- Monarch Initiative (monarchinitiative.org); Queen Mary University of London (United Kingdom). Genomics England
- Monarch Initiative (monarchinitiative.org); Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Environmental Genomics and Systems Biology
- Monarch Initiative (monarchinitiative.org); Wellcome Trust Genome Campus, Cambridge (United Kingdom). European Bioinformatics Institute (EMBL-EBI)
- Monarch Initiative (monarchinitiative.org); Oregon State Univ., Corvallis, OR (United States). Linus Pauling Inst.
- Monarch Initiative (monarchinitiative.org); Queen Mary Univ. College of London (United Kingdom). William Harvey Research Inst.; Univ. College of London (United Kingdom). UCL Genetics Inst.; University College of London (United Kingdom). UCL Inst. of Ophthalmology
- Monarch Initiative (monarchinitiative.org); Univ. of North Carolina, Chapel Hill, NC (United States). Renaissance Computing Inst.
- Government of Western Australia, Perth, WA (Australia). Dept. of Health. Western Australian Register of Developmental Anomalies and Genetic Services of Western Australia and The Office of Population Health Genomics; Univ. of Western Australia, Perth, WA (Australia). School of Paediatrics and Telethon Kids Inst.; Murdoch Univ., WA (Australia). Inst. for Immunology and Infectious Diseases; Curtin Univ., Perth, WA (Australia). Dept. of Science and Engineering. Spatial Sciences
- Curtin Univ., Perth, WA (Australia). Dept. of Science and Engineering. Spatial Sciences
- Government of Western Australia, Perth, WA (Australia). Dept. of Health. Western Australian Register of Developmental Anomalies and Genetic Services of Western Australia and The Office of Population Health Genomics
- Government of Western Australia, Perth, WA (Australia). Dept. of Health. The Office of Population Health Genomics
- SimulConsult, Chestnut Hill, MA, (United States)
- Vrije Univ., Brussels (Belgium). Neurogenetics Research Group; UZ Brussels (Belgium). Dept. of Pediatrics. Pediatric Neurology Unit
- Monarch Initiative (monarchinitiative.org); Garvan Inst. of Medical Research, Sydney, NSW (Australia)
- Univ. of Toronto, ON (Canada). Centre for Computational Medicine. Hospital for Sick Children. Dept. of Computer Science
- National Institutes of Health (NIH), Bethesda, MD (United States). National Inst. of Allergy and Infectious Diseases
- Marquette Univ., Milwaukee, WI (United States). Medical College of Wisconsin. Dept. of Biomedical Engineering. Rat Genome Database
- Bioscientia GmbH, Ingelheim (Germany)
- Barcelona Institute of Science and Technology (BIST), Barcelona (Spain). CNAG-CRG, Centre for Genomic Regulation (CRG); Univ. Pompeu Fabra, Barcelona (Spain)
- Univ. of Manchester (United Kingdom). Manchester Royal Eye Hospital
- The Jackson Lab. for Genomic Medicine, Farmington, CT (United States)
- ICF, Rockville, MD, (United States); National Institutes of Health (NIH), Bethesda, MD (United States). National Center for Advancing Translational Sciences. Office of Rare Diseases Research
- Orphanet, Paris (France). Plateforme Maladies Rares. INSERM
- The Jackson Lab., Bar Harbor, ME (United States)
- Sanford Health, Sioux Falls, SD (United States). Sanford Imagenetics
- Stanford Univ., CA (United States). School of Medicine. Center for Undiagnosed Diseases
- Univ. of Utrecht (Netherlands). Univ. Medical Center. Dept. of Genetics
- Orphanet, Paris (France). Plateforme Maladies Rares. INSERM
- Newcastle Univ., Newcastle upon Tyne (United Kingdom). Inst. of Genetic Medicine
- Stanford Univ., CA (United States). School of Medicine. Dept. of Pediatrics
- Icahn School of Medicine at Mount Sinai, New York, NY (United States)
- Univ. College London (United Kingdom). Inst. of Cardiovascular Science
- Vall d’Hebron Research Inst. (VHIR), Barcelona (Spain). Hospital Universitari Vall d’Hebron. Child Neurology Unit
- Barcelona Institute of Science and Technology (BIST), Barcelona (Spain). CNAG-CRG, Centre for Genomic Regulation (CRG); Univ. of Freiburg (Germany). Medical Center. Faculty of Medicine. Dept. of Neuropediatrics and Muscle Disorders; Univ. of Ottawa (Canada). Children’s Hospital of Eastern Ontario Research Inst.; The Ottawa Hospital, Ottawa (Canada). Dept. of Medicine. Division of Neurology
- Strasbourg Univ. Hospital, Strasbourg (France). SENSGENE FSMR Network. Centre for Rare Eye Diseases CARGO
- National Institutes of Health (NIH), Bethesda, MD (United States). Clinical Center. Dept. of Lab. Medicine. Immunology Service
- Univ. of Pennsylvania, Philadelphia, PA (United States). Perelman School of Medicine. The Children’s Hospital of Philadelphia. Dept. of Pediatrics. Division of Allergy Immunology
- Monarch Initiative (monarchinitiative.org); The Jackson Lab. for Genomic Medicine, Farmington, CT (United States); Univ. of Connecticut, Farmington, CT (United States). Inst. for Systems Genomics
The Human Phenotype Ontology (HPO)––a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases––is used by thousands of researchers, clinicians, informaticians and electronic health record systems around the world. Its detailed descriptions of clinical abnormalities and computable disease definitions have made HPO the de facto standard for deep phenotyping in the field of rare disease. The HPO’s interoperability with other ontologies has enabled it to be used to improve diagnostic accuracy by incorporating model organism data. It also plays a key role in the popular Exomiser tool, which identifies potential disease-causing variants from whole-exome or whole-genome sequencing data. Since the HPO was first introduced in 2008, its users have become both more numerous and more diverse. To meet these emerging needs, the project has added new content, language translations, mappings and computational tooling, as well as integrations with external community data. The HPO continues to collaborate with clinical adopters to improve specific areas of the ontology and extend standardized disease descriptions. The newly redesigned HPO website (www.human-phenotypeontology.org) simplifies browsing terms and exploring clinical features, diseases, and human genes.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1625571
- Journal Information:
- Nucleic Acids Research, Journal Name: Nucleic Acids Research Journal Issue: D1 Vol. 47; ISSN 0305-1048
- Publisher:
- Oxford University PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
The Human Phenotype Ontology in 2017
The Human Phenotype Ontology in 2021
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data
Journal Article
·
Wed Nov 23 19:00:00 EST 2016
· Nucleic Acids Research
·
OSTI ID:1408411
The Human Phenotype Ontology in 2021
Journal Article
·
Tue Dec 01 19:00:00 EST 2020
· Nucleic Acids Research
·
OSTI ID:1828340
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data
Journal Article
·
Sun Nov 10 19:00:00 EST 2013
· Nucleic Acids Research
·
OSTI ID:1625512